Jacek Winiarski

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Stamcellstransplantation hos barn och ungdomar

Med hematopoetisk stamcellstransplantation (HSCT) botas bl.a. leukemi, andra svåra blodsjukdomar, immundefekter och vissa metabola sjukdomar. HSCT kompliceras dock av toxiska biverkningar och av immunreaktioner mellan givar-och mottagarceller (GVHD). Det är även stor risk för återfall och seneffekter. I ett flertal olika projekt har dessa problem studerats för att förbättra utfallet av SCT liksom uppföljningen och omhändertagandet av de överlevande barnen. På Karolinska, Huddinge finns en stor gupp av patienter som genomgått denna behandling under barndomen alltsedan 1980.

Artiklar

Journal article: BLOOD. 2025;146:165
Hematopoietic stem cell transplantation in 746 children with osteopetrosis: A study of the inborn errors working party of the EBMT
Chiesa R; Albert MH; Gilbert P; Knippenberg J; Zaidman I; Alsaedi H; Porta F; Wynn RF; Muskatel RS; Aksoylar S; Kuskonmaz B; Nademi Z; Lawson S; Yesilipek A; Felgentreff K; Vicent MG; Silva J; Bykova T; Kupesiz OA; Zecca M; Faraci M; Hamidieh A; Abu Shanap M; Adam E; Ghafoor T; Karakukcu M; Maximova N; Van Lancker S; Paillard C; Renard M; Locatelli F; Castelle M; Amrolia P; Senthil S; Renard C; Essa M; Bruno B; Diaz-de-Heredia C; Furlan I; Formankova R; Felber M; Miranda N; Rao K; Malbora B; Winiarski J; Bredius R; James B; Diana J-S; Erdem M; Alseraihy A; Gabriel M; Gruhn B; Masmas T; Biffi A; Drabko K; Kalwak K; Bueno D; Hoenig M; Vaz C; Wustrau K; Brichard B; Ryhanen S; Villa A; Neven B; Sirin M; Moshous D; Schulz A
Article: BLOOD. 2024;144(8):873-887
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.
Chiang SCC; Covill LE; Tesi B; Campbell TM; Schlums H; Nejati-Zendegani J; Mördrup K; Wood S; Theorell J; Sekine T; Al-Herz W; Akar HH; Belen FB; Chan MY; Devecioglu O; Aksu T; Ifversen M; Malinowska I; Sabel M; Unal E; Unal S; Introne WJ; Krzewski K; Gilmour KC; Ehl S; Ljunggren H-G; Nordenskjöld M; Horne A; Henter J-I; Meeths M; Bryceson YT
Article: BLOOD. 2022;139(13):2066-2079
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis
Albert MH; Slatter MA; Gennery AR; Gungor T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kalwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallee TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
Article: SUPPORTIVE CARE IN CANCER. 2020;28(10):4869-4879
Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial
Kamsvag T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
Article: BLOOD ADVANCES. 2020;4(15):3754-3766
Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.
Bergsten E; Horne A; Hed Myrberg I; Aricó M; Astigarraga I; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Nanduri V; Rosso DA; Sieni E; Winiarski J; Henter J-I
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(2):293-300
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
El-Serafi I; Remberger M; Ringden O; Torlen J; Sundin M; Bjorklund A; Winiarski J; Mattsson J
Article: BLOOD ADVANCES. 2019;3(20):3123-3131
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Angel Diaz M; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gomez-Almaguer D; Gonzalez Vicent M; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldana BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1970-1974
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Andersson P-O; Brune M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1965-1969
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringden O
Article: TRANSPLANTATION. 2019;103(6):1247-1252
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor
Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
Article: BONE MARROW TRANSPLANTATION. 2019;54(5):726-736
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(6):982-993
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
Ifversen M; Turkiewicz D; Marquart HV; Winiarski J; Buechner J; Mellgren K; Arvidson J; Rascon J; Korgvee L-T; Madsen HO; Abrahamsson J; Lund B; Jonsson OG; Heilmann C; Heyman M; Schmiegelow K; Vettenranta K
Article: ACTA PAEDIATRICA. 2018;107(11):1995-2003
Children with mucopolysaccharidosis risk progressive visual dysfunction despite haematopoietic stem cell transplants
Fahnehjelm KT; Olsson M; Chen E; Hengstler J; Naess K; Winiarski J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(6):613-620
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2018;7(4):325-331
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Article: PEDIATRIC TRANSPLANTATION. 2018;22(2)
Visual perceptual skills and visual motor integration in children and adolescents after allogeneic hematopoietic stem cell transplantation
Fahnehjelm KT; Tornquist AL; Olsson M; Winiarski J; Ek U
Article: HAEMATOLOGICA. 2017;102(10):1683-1690
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Journal article: INTERNATIONAL JOURNAL OF NEONATAL SCREENING. 2017;3(2):11
Newborn Screening for Primary Immune Deficiencies with a TREC/KREC/ACTB Triplex Assay-A Three-Year Pilot Study in Sweden
Zetterstroem RH; Barbaro M; Ohlsson A; Borte S; Jonsson S; Winiarski J; von Doebeln U; Hammarstroem L
Article: CLINICAL IMMUNOLOGY. 2017;176:71-76
NEIL1 is a candidate gene associated with common variable immunodeficiency in a patient with a chromosome 15q24 deletion
Romano R; Zaravinos A; Liadaki K; Caridha R; Lundin J; Carlsson G; Winiarski J; Pan-Hammarstrom Q; Hammarstrom L
Article: CLINICAL NEUROPHYSIOLOGY PRACTICE. 2017;2:67-71
Visual evoked potentials after hematopoietic allogeneic stem cell transplantation in childhood
Tornquist AL; Andersson T; Winiarski J; Gronlund MA; Fahnehjelm KT
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2017;37(1):51-60
Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterstrom RH; King J; Winiarski J; von Dobeln U; Hammarstrom L
Article: HAEMATOLOGICA. 2016;101(11):1417-1425
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2016;20(5):667-674
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades
Svenberg P; Remberger M; Uzunel M; Mattsson J; Gustafsson B; Fjaertoft G; Sundin M; Winiarski J; Ringden O
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2016;36(5):480-489
Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation
Tesi B; Priftakis P; Lindgren F; Chiang SCC; Kartalis N; Lofstedt A; Lorinc E; Henter J-I; Winiarski J; Bryceson YT; Meeths M
Article: ONCOTARGET. 2016;7(21):30230-30240
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
Li Q; Rane L; Poiret T; Zou J; Magalhaes I; Ahmed R; Du Z; Vudattu N; Meng Q; Gustafsson-Jernberg A; Winiarski J; Ringden O; Maeurer M; Remberger M; Ernberg I
Article: PEDIATRIC TRANSPLANTATION. 2016;20(1):96-104
HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT
Thorvaldson L; Remberger M; Winiarski J; Omazic B; Fischler B; Sundin M
Article: ACTA PAEDIATRICA. 2016;105(1):82-89
Cataract after allogeneic hematopoietic stem cell transplantation inchildhood
Fahnehjelm KT; Tornquist AL; Olsson M; Backstrom I; Gronlund MA; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2015;19(7):758-766
Chimerism analysis in clinical practice and its relevance for the detection of graft rejection and malignant relapse in pediatric hematopoietic stem cell transplant patients
Mellgren K; Arvidson J; Toporski J; Winiarski J
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2015;174(6):801-807
Neutropenia in childhood: a 5-year experience at a tertiary center
Lindqvist H; Carlsson G; Moell J; Winiarski J; Sundin M
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):850-857
Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up
Wilhelmsson M; Vatanen A; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: PEDIATRIC BLOOD & CANCER. 2015;62(5):890-896
Hypogammaglobulinemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Cytokine Mediated Immunoglobulin Isotype Class Switch Arrest?
Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;169(1):103-110
Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases
Tucunduva L; Volt F; Cunha R; Locatelli F; Zecca M; Yesilipek A; Caniglia M; Guengoer T; Aksoylar S; Fagioli F; Bertrand Y; Addari MC; de la Fuente J; Winiarski J; Biondi A; Sengeloev H; Badell I; Mellgren K; de Heredia CD; Sedlacek P; Vora A; Rocha V; Ruggeri A; Gluckman E
Article: CLINICAL IMMUNOLOGY. 2014;155(1):74-78
Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome
Borte S; Fasth A; von Dobeln U; Winiarski J; Hammarstrom L
Article: PSYCHO-ONCOLOGY. 2014;23(11):1307-1313
Patterns of psychological responses in parents of children that underwent stem cell transplantation
Riva R; Forinder U; Arvidson J; Mellgren K; Toporski J; Winiarski J; Norberg AL
Article: JOURNAL OF IMMUNOTHERAPY. 2014;37(8):416-425
TCR⁺CD4^-CD8^- T cells in Antigen-specific MHC Class I-restricted T-cell Responses After Allogeneic Hematopoietic Stem Cell Transplantation
Ahmed RK; Poiret T; Ambati A; Rane L; Remberger M; Omazic B; Vudattu NK; Winiarski J; Ernberg I; Axelsson-Robertson R; Magalhaes I; Castelli C; Ringden O; Maeurer M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1646-1649
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1537-1543
Vitamin D Levels Affect Outcome in Pediatric Hematopoietic Stem Cell Transplantation
Hansson MEA; Norlin A-C; Omazic B; Wikstrom A-C; Bergman P; Winiarski J; Remberger M; Sundin M
Article: BMC IMMUNOLOGY. 2014;15:25
Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
Poiret T; Rane L; Remberger M; Omazic B; Gustafsson-Jernberg A; Vudattu NK; Ahmed R; Ernberg I; Winiarski J; Magalhaes I; Ringden O; Maeurer M
Article: PEDIATRIC BLOOD & CANCER. 2014;61(6):1094-1100
Adult Testicular Volume Predicts Spermatogenetic Recovery After Allogeneic HSCT in Childhood and Adolescence
Wilhelmsson M; Vatanen A; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: PEDIATRIC TRANSPLANTATION. 2014;18(3):302-309
Relationship between problems related to child late effects and parent burnout after pediatric hematopoietic stem cell transplantation
Lindahl Norberg A; Mellgren K; Winiarski J; Forinder U
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2014;34(4):469-477
Novel STAT3 Mutation Causing Hyper-IgE Syndrome: Studies of the Clinical Course and Immunopathology
Sundin M; Tesi B; Bohme MS; Bryceson YT; Putsep K; Chiang SC; Thunberg S; Winiarski J; Wikstorm A-C
Article: ACTA OPHTHALMOLOGICA. 2014;92(2):171-178
Ocular manifestations and visual functions in patients with Fanconi anaemia
Tornquist AL; Martin L; Winiarski J; Fahnehjelm KT
Article: HAEMATOLOGICA. 2014;99(2):346-352
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2014;170(2):211-218
Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence
Vatanen A; Wilhelmsson M; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: ACTA PAEDIATRICA. 2013;102(11):1087-1094
Chronic granulomatous disease - haematopoietic stem cell transplantation versus conventional treatment
Ahlin A; Fugelang J; de Boer M; Ringden O; Fasth A; Winiarski J
Article: BLOOD. 2013;121(8):1345-1356
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production
Chiang SCC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiold C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjold M; Ljunggren H-G; Henter J-I; Bryceson YT
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(2):325-328
Folinic Acid Supplementation in Higher Doses is Associated with Graft Rejection in Pediatric Hematopoietic Stem Cell Transplantation
Lindqvist H; Remberger M; Harila-Saari A; Winiarski J; Sundin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(12):1776-1784
Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research
Buchbinder D; Nugent DJ; Brazauskas R; Wang Z; Aljurf MD; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
Article: PEDIATRIC TRANSPLANTATION. 2012;16(8):866-871
Subcutaneous IgG replacement after pediatric SCT
Sundin M; Nordin K; Jostemyr Y; Winiarski J
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2012;16(6):E241-E245
Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia
Gustafsson B; Moell J; LeBlanc K; Barbany G; Soderhall S; Winiarski J
Article: PLOS ONE. 2012;7(8):e43419
Placental Transfer of Maternally-Derived IgA Precludes the Use of Guthrie Card Eluates as a Screening Tool for Primary Immunodeficiency Diseases
Borte S; Janzi M; Pan-Hammarstrom Q; von Dobeln U; Nordvall L; Winiarski J; Fasth A; Hammarstrom L
Article: ACTA OPHTHALMOLOGICA. 2012;90(5):445-448
Corneal hysteresis in mucopolysaccharidosis I and VI
Fahnehjelm KT; Chen E; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2012;90(3):287-290
Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler)
Fahnehjelm KT; Tornquist AL; Winiarski J
Article: LANCET. 2012;379(9823):1301-1309
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Mueller I; Stein J; Wynn R; Greil J; Sykora K-W; Matthes-Martin S; Fuehrer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Koerholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin K-M; Peters C; Dini G
Article: BLOOD. 2012;119(11):2552-2555
Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR
Borte S; von Dobeln U; Fasth A; Wang N; Janzi M; Winiarski J; Sack U; Pan-Hammarstrom Q; Borte M; Hammarstrom L
Article: BLOOD. 2011;118(22):5783-5793
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D
Meeths M; Chiang SCC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjold E; Bjorklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist B-M; Rajic L; Pfeifer S; Rosthoj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren H-G; Fadeel B; Nordenskjold M; Henter J-I; Bryceson YT
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: PEDIATRIC TRANSPLANTATION. 2011;15(7):691-698
The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood
Lof CM; Winiarski J; Ljungman P; Forinder U
Article: PEDIATRIC BLOOD & CANCER. 2011;56(3):444-451
Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: BONE MARROW TRANSPLANTATION. 2011;46(3):372-378
Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse
Rubin J; Vettenranta K; Vettenranta J; Bierings M; Abrahamsson J; Bekassy AN; Hakansson Y; Frost B-M; Arvidson J; Spendilow C; Winiarski J; Gustafsson B
Article: ACTA OPHTHALMOLOGICA. 2011;89(1):62-69
Visual field results and optic disc morphology in patients treated with allogeneic stem-cell transplantation in childhood
Tornquist AL; Olsson M; Martin L; Winiarski J; Fahnehjelm KT
Article: BLOOD. 2009;114(19):4117-4127
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity
Wood SM; Meeths M; Chiang SCC; Bechensteen AG; Boelens JJ; Heilmann C; Horiuchi H; Rosthoj S; Rutynowska O; Winiarski J; Stow JL; Nordenskjold M; Henter J-I; Ljunggren H-G; Bryceson YT
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2009;43(6):461-468
Health-related quality of life in adult survivors after paediatric allo-SCT
Lof CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
Article: BONE MARROW TRANSPLANTATION. 2008;42(8):515-522
Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning
Smedler A-C; Winiarski J
Article: SOCIAL WORK IN HEALTH CARE. 2008;47(2):157-173
Long-term psychosocial support for families of children who have undergone allogeneic stem cell transplant
Forinder U; Posse E; Winiarski J
Journal article: ACTA OPHTHALMOLOGICA. 2008;86(3):253-258
Dry-eye syndrome after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Törnquist A-L; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2008;86(3):253-258
Dry-eye syndrome after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Tornquist A-L; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2008;41(8):737-742
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2008;41(7):621-625
Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population:: A comparative study between the standard 4-dose and a 2-dose regimen
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringden O; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2007;40(11):1055-1062
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Article: ACTA PAEDIATRICA. 2007;96(11):1660-1664
Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure
Honkaniemi E; Gustafsson B; Fischler B; Nemeth A; Frost B-M; Papadogiannakis N; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2007;85(7):724-733
Visual outcome and cataract development after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Tornquist A-L; Olsson M; Winiarski J
Article: BLOOD. 2007;110(6):1906-1915
Defective cytotoxic lymphocyte degranulation in syntaxin-11-deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients
Bryceson YT; Rudd E; Zheng C; Edner J; Ma D; Wood SM; Bechensteen AG; Boelens JJ; Celkan T; Farah RA; Hultenby K; Winiarski J; Roche PA; Nordenskjold M; Henter J-I; Long EO; Ljunggren H-G
Article: BONE MARROW TRANSPLANTATION. 2007;39(11):717-723
Long-term renal function following bone marrow transplantation
Gronroos MH; Bolme P; Winiarski J; Berg UB
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2007;11(2):145-151
Risk factors for lower health-related QoL after allogeneic stem cell transplantation in children
Lof CM; Forinder U; Winiarski J
Article: PEDIATRIC BLOOD & CANCER. 2007;48(2):124-131
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
Henter J-I; Horne A; Aricó M; Egeler RM; Filipovich AH; Imashuku S; Ladisch S; McClain K; Webb D; Winiarski J; Janka G
Article: ACTA OPHTHALMOLOGICA. 2006;84(6):781-785
Ocular findings in four children with mucopolysaccharidosis I-Hurler (MPS I-H) treated early with haematopoietic stem cell transplantation
Fahnehjelm KT; Tornquist A-L; Malm G; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2006;10(4):491-496
Quality of life following allogeneic stem cell transplantation, comparing parents' and children's perspective
Forinder U; Lof C; Winiarski J
Article: TRANSPLANTATION. 2006;81(5):718-725
Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single center
Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: HAEMATOLOGICA. 2006;91(3):401-404
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen
Giraud G; Bogdanovic G; Priftakis P; Remberger M; Svahn B-M; Barkholt L; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: HAEMATOLOGICA. 2006;91(1):78-83
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation
Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringden O
Journal article: BLOOD. 2005;106(11):3239
Fatal Infectious Complications Developing Late after Allogeneic Stem Cell Transplantation.
Bjorklund A; Aschan J; Ringden O; Winiarski JH; Ljungman PT
Article: BONE MARROW TRANSPLANTATION. 2005;36(2):171-176
Quality of life and health in children following allogeneic SCT
Forinder U; Lof C; Winiarski J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;129(5):622-630
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
Horne A; Janka G; Maarten Egeler R; Gadner H; Imashuku S; Ladisch S; Locatelli F; Montgomery SM; Webb D; Winiarski J; Filipovich AH; Henter J-I; Histiocyte Society
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2004;34(12):1067-1069
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2004;42(11):5394-5396
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation
Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Article: PEDIATRIC TRANSPLANTATION. 2004;8(5):464-474
Risk factors in pediatric stem cell transplantation for leukemia
Jernberg Å; Remberger M; Ringdén O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2004;34(7):589-593
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease
Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Article: TRANSPLANTATION. 2004;78(3):415-419
Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors
Malm G; Månsson JE; Winiarski J; Mosskin M; Ringdén O
Article: TRANSPLANTATION. 2004;77(4):526-531
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus
Larsson K; Aschan J; Remberger M; Ringdén O; Winiarski J; Ljungman P
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2003;82(9):803-806
Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period
Tiblad E; Olsson I; Petersson K; Shanwell A; Winiarski J; Wolff K; Westgren M
Article: PEDIATRIC BLOOD & CANCER. 2003;40(4):219-223
Human polyomavirus DNA is not detected in guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia
Priftakis P; Dalianis T; Carstensen J; Samuelsson U; Lewensohn-Fuchs I; Bogdanovic G; Winiarski J; Gustafsson B
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):175-181
Graft-versus-leukaemia effect in children:: chronic GVHD has a significant impact on relapse and survival
Jernberg Å; Remberger M; Ringdén O; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2003;7(1):31-37
Megakaryocyte chimerism after allogeneic stem cell transplantation in children
Eklund O; Dalianis T; Wester D; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2002;30(12):833-841
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation:: 500 mg/m² as a optimal total dose for conditioning
Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
Article: ACTA PAEDIATRICA. 2002;91(8):974-977
Findings in familial haemophagocytic lymphohistiocytosis prior to symptomatic presentation
Hafsteinsdóttir S; Jónmundsson GK; Kristinsson JR; Winiarski J; Henter JI; Haraldsson A
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2001;18(8):497-508
MDM2 and p53 in childhood acute lymphoblastic leukemia: Higher expression in childhood leukemias with poor prognosis compared to long-term survivors
Gustafsson B; Axelsson B; Gustafsson B; Christensson B; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):479-485
Pharmacokinetics of liposomal busulphan in man
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(1):50-56
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2000;25(10):1059-1065
Unrelated bone marrow transplantation in children:: outcome and a comparison with sibling donor grafting
Gustafsson Å; Remberger M; Winiarski J; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 2000;4(2):132-139
Follow-up of chimerism, including T- and B-lymphocytes and granulocytes in children more than one year after allogeneic bone marrow transplantation.
Winiarski J; Gustafsson A; Wester D; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2000;25(8):843-851
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Article: TRANSPLANTATION. 2000;69(5):822-826
Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation
Bågesund M; Winiarski J; Dahllöf G
Article: PEDIATRIC BLOOD & CANCER. 2000;34(2):117-124
Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis
Gustafsson B; Christenson B; Gustafsson B; Hjalmar V; Winiarski J
Article: BLOOD. 2000;95(3):807-814
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells
Gustafsson Å; Levitsky V; Zou JZ; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci MG
Article: NATURE GENETICS. 1999;21(1):84-90
Mutations in the gene encoding B1 subunit of H⁺-ATPase cause renal tubular acidosis with sensorineural deafness
Karet FE; Finberg KE; Nelson RD; Nayir A; Mocan H; Sanjad SA; Rodriguez-Soriano J; Santos F; Cremers CWRJ; Di Pietro A; Hoffbrand BI; Winiarski J; Bakkaloglu A; Ozen S; Dusunsel R; Goodyer P; Hulton SA; Wu DK; Skvorak AB; Morton CC; Cunningham MJ; Jha V; Lifton RP
Article: TRANSPLANTATION. 1998;66(10):1330-1334
Results of different strategies for reducing:: Cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 1998;2(4):288-293
Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children.
Bogdanovic G; Priftakis P; Taemmeraes B; Gustafsson A; Flaegstad T; Winiarski J; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761
Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies
Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):73-78
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation
Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Article: PEDIATRIC TRANSPLANTATION. 1998;2(2):150-156
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Article: TRANSPLANTATION. 1997;64(8):1207-1208
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation on for non-A, non-B, non-C hepatitis
Hagglund H; Winiarski J; Ringden O; Sparrelid E; Ericzon BG
Article: ACTA PAEDIATRICA. 1997;86(5):484-492
Treatment of adrenoleukodystrophy with bone marrow transplantation
Malm G; Ringden O; Anvret M; vonDobeln U; Hagenfeldt L; Isberg B; Knuutila S; Nennesmo I; Winiarski J; Marcus C
Article: BONE MARROW TRANSPLANTATION. 1997;19(9):905-908
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
Sparrelid E; Ljungman P; EkelofAndstrom E; Aschan J; Ringden O; Winiarski J; Wahlin B; Andersson J
Article: TRANSPLANTATION. 1996;62(8):1076-1080
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ericzon BG; Duraj F; Ljungman P; Lonnqvist B; Winiarski J; Tyden G
Article: CLINICAL INFECTIOUS DISEASES. 1996;23(1):167-169
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation
Ljungman P; Andersson J; Aschan J; Bjorkstrand B; Hagglund H; Lonnqvist B; Ringden O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1996;17(6):1003-1008
Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow-transplantation
Malm G; Ringden O; Winiarski J; Grondahl E; Uvebrant P; Eriksson U; Hakansson H; Skjeldal O; Mansson JE
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):583-587
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients
Ljungman P; Lore K; Aschan J; Klaesson S; LewensohnFuchs I; Lonnqvist B; Ringden O; Winiarski J; Ehrnst A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1996;56(4):230-234
Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes
Arfors L; Winiarski J; Lefvert AK
Article: ACTA PAEDIATRICA. 1996;85(3):327-335
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital
Winiarski J; Ringden O; Remberger M; Dalianis T; Ljungman P; Borgstrom B
Article: ACTA PAEDIATRICA. 1996;85(2):168-172
Fungal pneumonia: The predominant lung infection causing death in children undergoing bone marrow transplantation
Heurlin N; Bergstrom SE; Winiarski J; Ringden O; Ljungman P; Lonnqvist B; Andersson J
Article: TRANSPLANTATION. 1995;60(11):1225-1230
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringden O; Ljungman P; Aschan J; Hagglund H; Winiarski J
Article: BLOOD. 1995;86(4):1614-1618
LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: LAKARTIDNINGEN. 1995;92(9):860-864
[Thrombocytopenia in pregnant women and newborn infants. An appeal for a common care program].
Elinder G; Bremme C; Olsson I; Shanwell A; Wegnelius G; Westgren M; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):331-335
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN SWEDEN
BOLME P; HENTER JI; WINIARSKI J; ELINDER G; LJUNGMAN P; LONNERHOLM G; RINGDEN O
Journal article: LAKARTIDNINGEN. 1991;88(25):2308-2311
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life].
Ljungman P; Aschan J; Bolme P; Lindqvist R; Lönnqvist B; Ringdén O; Winiarski J; Gahrton G
Journal article: BONE MARROW TRANSPLANTATION. 1991;7(2):113-119
METHOTREXATE COMBINED WITH CYCLOSPORINE-A DECREASES GRAFT-VERSUS-HOST DISEASE, BUT INCREASES LEUKEMIC RELAPSE COMPARED TO MONOTHERAPY
ASCHAN J; RINGDEN O; SUNDBERG B; GAHRTON G; LJUNGMAN P; WINIARSKI J
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(1):198-202
BONE-MARROW TRANSPLANTATION FOR METABOLIC DISORDERS AT HUDDINGE-HOSPITAL
RINGDEN O; GROTH CG; ASCHAN J; BOLME P; LJUNGMAN P; LONNQVIST B; MALM G; MANSSON JE; SHANWELL A; SVENNERHOLM L; TOLLEMAR J; WINIARSKI J
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 1990;65(1):137-139
PLATELET ANTIGENS IN VARICELLA ASSOCIATED THROMBOCYTOPENIA
WINIARSKI J
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1989;73(1):88-92
IGG AND IGM ANTIBODIES TO PLATELET MEMBRANE GLYCOPROTEIN ANTIGENS IN ACUTE CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1989;43(1):29-34
ANTIBODIES TO PLATELET MEMBRANE GLYCOPROTEIN ANTIGENS IN 3 CASES OF INFECTIOUS MONONUCLEOSIS-INDUCED THROMBOCYTOPENIC PURPURA
WINIARSKI J
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):487-490
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHILDREN AT HUDDINGE-HOSPITAL
RINGDEN O; BOLME P; LONNQVIST B; TOLLEMAR J; BORGSTROM B; DOHLHOF G; LUNDGREN G; WINIARSKI J; GAHRTON G; GROTH CG
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1986;37(3):175-179
IMMUNOLOGICAL EFFECTS OF INTRAVENOUS GAMMA-GLOBULIN TREATMENT IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; ELINDER G
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1986;63(2):459-465
ANTIBODY-BINDING TO PLATELET ANTIGENS IN ACUTE AND CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA - A PLATELET MEMBRANE ELISA FOR THE DETECTION OF ANTIPLATELET ANTIBODIES IN SERUM
WINIARSKI J; EKELUND E
Journal article: BLUT. 1985;51(4):259-266
IMMUNOGLOBULIN BINDING TO PLATELETS - THE EFFECT OF AGGREGATED IGG
WINIARSKI J
Journal article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 1984;1(1):207-211
Platelet associated IgM in acute idiopathic thrombocytopenic purpura. High-dose intravenous IgG compared to prednisolone
Winiarski J
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1983;31(4):342-348
HIGH-DOSE INTRAVENOUS IGG REDUCES PLATELET ASSOCIATED IMMUNOGLOBULINS AND COMPLEMENT IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; KREUGER A; EJDERHAMN J; HOLM G
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1983;53(1):201-207
PLATELET ASSOCIATED IMMUNOGLOBULINS AND COMPLEMENT IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; HOLM G
Journal article: OBSTETRICAL & GYNECOLOGICAL SURVEY. 1981;36(7):356-357
Premature Rupture of the Membranes
EVALDSON G; LAGRELIUS A; WINIARSKI J
Journal article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 1980;59(5):385-393
PREMATURE RUPTURE OF THE MEMBRANES
EVALDSON G; LAGRELIUS A; WINIARSKI J
Visa fler

Alla övriga publikationer

Review: STEM CELLS. 2024;42(4):291-300
Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease
Ringden O; Sadeghi B
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E74-E77
Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT-An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
Wilhelmsson M; Jahnukainen K; Winiarski J; Abrahamsson J; Bautz A; Gudmundsdottir T; Madanat-Harjuoja L-M; Holmqvist AS; Winther JF; Hasle H
Conference publication: BONE MARROW TRANSPLANTATION. 2019;54:300
Long term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease
Ringden O; Remberger M; Gustafsson B; Winiarski J; Khoein B; Klingspor L; Westgren M; Mattsson J; Sadeghi B
Conference publication: CYTOTHERAPY. 2019;21(5):S74
LONG-TERM FOLLOW UP OF A PILOT STUDY USING PLACENTA DERIVED DECIDUA STROMAL CELLS FOR SEVERE ACUTE GRAFT VERSUS HOST DISEASES
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Kingspor L; Westgren M; Mattsson J; Ringden O
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):s247
Long Term Follow-up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-Versus-Host Disease
Ringden O; Remberger M; Gustafsson B; Winiarski J; Khoein B; Klingspor L; Westgren M; Mattsson J; Sadeghi B
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):s16
Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen for Patients with Wiskott-Aldrich Syndrome - an EBMT Inborn Errors Working Party and Scetide Study
Albert MH; Slatter M; Gennery A; Gungor T; Blok H-J; Hazelaar S; Wang J; Courteille V; Mahlaoui N; Bernado ME; Bodova I; Bruno B; Bykova T; Chiesa R; Fischer A; Formankova R; Kalwak K; Klein C; Kozlovskaya S; Kupesiz A; Locatelli F; Moshous D; Neven B; Porta F; Schulz A; Sykora K-W; Karakukcu M; Winiarski J; Zecca M; Veys P; Lankester AC
Conference publication: BLOOD. 2018;132:2175
Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation - an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis
Albert MH; Slatter M; Gennery A; Guengoer T; Blok H-J; Wang J; Courteille V; Bernardo ME; Bodova I; Bruno B; Bykova TA; Chiesa R; Fischer A; Formankova R; Kalwak K; Klein C; Kozlovskaya S; Kupesiz OA; Locatelli F; Mahlaoui N; Moshous D; Neven B; Porta F; Schulz A; Sykora K-W; Unal E; Winiarski JH; Zecca M; Veys P; Lankester A
Conference publication: PEDIATRIC BLOOD & CANCER. 2018;65:S232-S233
Burden of Hospitalizations in Long-Term Survivors of Childhood AML Treated with Allogeneic-HSCT: An ALiCCs Study
Wilhelmsson M; Winiarski J; Winther JF; Gudmundsdottir T; Madanat-Harjuoja L; Olsen JH; Jahnukainen K; Hasle H
Conference publication: BONE MARROW TRANSPLANTATION. 2018;53:347-348
Long-term health outcomes and fertility in survivors of childhood AML treated with allogeneic HSCT: A NOPHO-AML Study
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H
Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S360-S361
Oral Cryotherapy to Reduce the Incidence of Severe Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation: Results of a Randomized Clinical Trial
Magnusson TK; von Essen L; Arvidson J; Svanberg A; Mellgren K; Garming-Legert K; Toporski J; Winiarski J; Ljungman G
Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;139(5):1713-1716.e6
Costs associated with treatment of severe combined immunodeficiency-rationale for newborn screening in Sweden
Gardulf A; Winiarski J; Thorin M; Arnlind MH; von Dobeln U; Hammarstrom L
Conference publication: TRANSPLANTATION. 2016;100(7):S438
Placenta-derived decidual stromal cells for treatment of severe acute graft-versus-host disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Westgren M; Sadeghi B; Kaipe H
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S48
Placenta-Derived Decidual Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustavsson B; Winiarski J; Westgren M; Sadeghi B; Mattsson J; Kaipe H
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21
A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S377
Placenta-derived decidual stromal cells for treatment of severe acute graft-versus-host disease
Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Sadeghi B; Kaipe H; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S264-S265
SIGNIFICANTLY REDUCED RISK OF SINUSOIDAL OBSTRUCTION SYNDROME OF THE LIVER IN RECENT YEARS IN PATIENTS RECEIVING BUCY PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Mattsson J; Ringden O; Engstrom M; Berglund S; Ljungman P; Winiarski J; Uhlin M; Svahn B-M; Remberger M; Hassan M
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):S173
Superior Survival Rate Following Conditioning with Etoposide in Childhood ALL
Ifversen M; Winiarski J; Saarinen-Pihkala U; Mellgren K; Glomstein A; Arvidson J; Lahtenmaaki P; Toporski J; Rosthoej S; Heyman M; Heilmann C
Meeting abstract: BLOOD. 2013;122(21):5483
The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation
Hansson MEA; Norlin A-C; Omazic B; Wikstroem A-C; Winiarski J; Remberger M; Sundin M
Meeting abstract: BLOOD. 2013;122(21):5473
Hypogammaglobulinemia In Children Undergoing SCT: A Immunoglobulin Isotype Class Switch Arrest?
Lindqvist H; Remberger M; Sundberg B; Uzunel M; Winiarski J; Sundin M
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S301
Varicella zoster virus disease after allogeneic haematopoietic stem cell transplantation. Incidence, risk factors and complications
Fjaertoft G; Winiarski J; Ljungman P; Uhlin M; Remberger M; Mattsson J
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S48
Risk factors for Epstein Barr virus-related post-transplant lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Mauerer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Conference publication: JOURNAL OF CLINICAL IMMUNOLOGY. 2012;32:252
COMBINED NEONATAL SCREENING FOR SCID AND XLA USING TRECS AND KRECS
Borte S; von Dobeln U; Fasth A; Wang N; Janzi M; Winiarski J; Pan-Hammarstrom Q; Sack U; Borte M; Hammarstrom L
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S226
LATE EFFECTS IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH ACQUIRED SEVERE APLASTIC ANEMIA: A REPORT FROM THE LATE EFFECTS WORKING COMMITTEE OF THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH (CIBMTR)
Buchbinder D; Nugent D; Brazauskas R; Wang Z; Aljurf M; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168
Improved survival after allogeneic haematopoietic stem cell transplantation in recent years
Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S142-S143
Changes in allogeneic haematopoietic stem cell transplantation in children during the last two decades
Svenberg P; Remberger M; Gustafsson B; Hassan Z; Mattsson J; Winiarski J; Ringden O
Review: LAKARTIDNINGEN. 2010;107(42):2576-2580
[Transplantation gives severely ill children a chance to life].
Németh A; Berg U; Winiarski J
Conference publication: QUALITY OF LIFE RESEARCH. 2010;19:76
To survey young stem cell transplanted (SCT) patients HRQOL as an intergrated part of the comprehensive care program, can this affect the planning of follow-up care?
Lof CM; Forinder U; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2010;45:S208
Norovirus infections in patients after stem cell transplantation: epidemiological and clinical aspects
Ljungman P; Mattsson J; Winiarski J; Sparrelid E; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2010;45:S1
Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Boelens JJ; Uderzo C; Hewitt N; Rovelli A; Schrum J; Mueller I; Schulz A; Stein J; Wynn R; Greil J; Matthes S; Sykora K; Albert M; O'Meare A; Massaro J; D'Agostino R; Pfitzenmaier M; Sedlacek P; Schlegel P; Arvidson J; Toporski J; Groll A; Fasth A; Winiarski J; Ozsahin H; Schrauder A; Bader P; Hoyle M; Iacobelli M; Dini G; Peters C
Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S241-S242
CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
Avetisyan G; Hagglund H; Hassan Z; LeBlanc K; Mattsson J; Ringden O; Winiarski J; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S60
EBV associated PTLD after allogeneic stem cell transplant patients
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S371
Subcutaneous immunoglobulin as an alternative route in children after allogenic haematopoietic stem cell transplantation
Jostemyr Y; Nordin K; Hjelt A-C; Winiarski J
Meeting abstract: BLOOD. 2007;110(11):2969-872A
Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski JH; Yun Z; Ljungman PT
Conference publication: PSYCHO-ONCOLOGY. 2007;16(9):S136-S137
Life situation for young adults who have undergone SCT (stem cell transplantation) as children
Forinder U; Lof C; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2007;39:S297
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in haematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2006;24(36):5750-5762
Pathways through relapses and deaths of children with acute lymphoblastic leukemia:: Role of allogeneic stem-cell transplantation in Nordic data
Saarinen-Pihkala UM; Heilmann C; Winiarski J; Glomstein A; Abrahamsson J; Arvidson J; Bekassy AN; Forestier E; Jonmundsson G; Schroeder H; Vettenranta K; Wesenberg F; Gustafsson G
Conference publication: BONE MARROW TRANSPLANTATION. 2006;37:S204
Safe administration of oral busulphan b.i.d during conditioning for stem cell transplantation in a paediatric population -: a comparative study between the standard 4-dose regimen and a 2-dose regimen
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Söderhäll S; Winiarski J; Hassan M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):126
Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center
Mattson J; Remberger M; Svahn BM; Svenberg P; Winiarski J; Ringden O
Conference publication: BLOOD. 2005;106(11):905A
Fatal infectious complications developing late after allogeneic stem cell transplantation.
Bjorklund A; Aschan J; Ringden O; Winiarski JH; Ljungman PT
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S346
Studies on BIK virus load in urine samples and graft-versus-host disease in relation to risk for development of haemorrhagic cystitis in allogeneic haematopoetic stem cell transplanted patients
Giraud G; Bogdanovic G; Priftakis P; Remberger M; Kokhaei P; Mellstedt H; Ljungman P; Winiarski J; Dalianis T
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S267
Allogeneic haematopoietic stem cell transplantation for metabolic disorders, a single-centre experience
Ringden O; Remberger M; Svahn B; Barkholt L; Aschan J; Mattsson J; Le Blanc K; Gustafsson B; Hassan Z; Svenberg P; Solders G; von Dobeln U; Winiarski J; Ljungman P; Malm G
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S27
Risk factors for development of CMV disease after allogeneic stem cell transplantation in the era of viral load monitoring
Ljungman P; Pérez-Bercoff L; Jonsson J; Sparrelid E; Aschan J; Barkholt L; Larsson K; Lewensohn-Fuchs I; Winiarski J; Yun Z; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S201
A high BK virus load in urine samples combined with graft-versus-host disease frequently precedes and may predict a risk for haemorrhagic cystitis in haematopoietic stem cell transplanted patients
Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Conference publication: BLOOD. 2003;102(11):707A
Correlation between busulphan concentration and transplantation related toxicity in patients undergoing SCT.
Hassan M; Aschan J; Hassan Z; Ringden O; Winiarski J; Ljungman P; Oberg G
Conference publication: PEDIATRIC RESEARCH. 2003;53(4):293A
Bone marrow transplantation in chronic granulomatous disease - A comparison with conventional treatment and a presentation of two new cases
Ahlin A; Ringden O; Winiarski J
Conference publication: BLOOD. 2002;100(11):41A
Hematopoietic stem cell transplantation in 90 children with hemophagocytic lymphohistiocytosis (HLH): Results of the HLH-94 study.
Henter JI; Horne A; Arico M; Egeler M; Gadner H; Imashuku S; Janka G; Ladisch S; Montgomery SM; Webb D; Winiarski J; Filipovich A
Conference publication: BLOOD. 2000;96(11):388A
Phase I clinical trial of liposomal busulphan.
Hassan M; Nilsson C; Ljungman P; Hassau Z; Ringdén O; Hentschke P; Winiarski J; Aschan J
Conference publication: BLOOD. 2000;96(11):387A
Pharmacokinetics of liposomal busulfan in man.
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Conference publication: BLOOD. 1998;92(10):653A
Adoptive transfer of Epstein-Barr virus specific cytotoxic T-cells to patients at risk for posttransplant lymphoproliferative disease reduces the EBV DNA load in peripheral blood lymphocytes (PBL).
Gustafsson Å; Levitsky V; Zou JZ; Winiarski J; Frisan T; Ljungman P; Dalianis T; Ringdén O; Ernberg I; Masucci MG
Conference publication: BLOOD. 1998;92(10):357B
Results of bone marrow transplantation in Ph+ all using related or unrelated HLA-A, -B and -DR identical donors.
Larsson K; Lonnqvist B; Winiarski J; Ringdén O; Ljungman P
Published conference paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1998;87:54-56
Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP)
Winiarski J
Published conference paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1998;87:51-53
Measurement of platelet antibodies: where do we stand?
Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S119
Clinical effects of intravenous immune globulin treatment after bone marrow transplantation, using HLA matched unrelated donors
Klaesson S; Hagglund H; Ljungman P; Carlens S; Mattsson J; Remberger M; Sparrelid E; Winiarski J; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S2
Results of bone marrow transplantation in Ph+ ALL using related or unrelated HLA-A, -B and -DR identical donors
Larsson K; Winiarski J; Lonnqvist B; Ringden O; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S217
EBV-associated lymphomas of different origin in two children after T-cell depleted bone marrow transplantation.
Gustafsson Å; Winiarski J; Ringdén O; Mattson J; Dalianis T; Christensson B
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S184
Post-BMT monitoring of 40 patients by PCR-amplification of immunomagnetically immobilized cells to detect minimal residual disease.
Mattsson J; Zetterquist H; Tammik L; Uzunel M; Winiarski J; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S32
Low incidence of acute graft-versus-host disease, using unrelated HLA-A, -B, and -DR identical donors and conditioning, including anti-T-cell antibodies.
Ringden O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lonnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S183
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Gustafsson Å; Borgström B; Mattson J; Wester D; Ringden O; Ljungman P; Dalianis T
Conference publication: BRAIN PATHOLOGY. 1997;7(4):1348
Treatment of adrenoleukodystrophy with bone marrow transplantation
Malm G; Ringden O; Anvret W; vonDobeln U; Hagenfeldt L; Isberg B; Knuutila S; Nennesmo I; Winiarski J; Marcus C
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736
A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate
Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S62-S64
Transplantation of peripheral blood progenitor cells from unrelated donors
Ringden O; Potter MN; Oakhill A; Cornish J; Hagglund H; Lonnqvist B; Shanwell A; Winiarski J; Pamphilon DH
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3528-3529
Less acute GVHD in patients receiving totally matched transplants from unrelated donors
Lonnqvist B; Ljungman P; Norrby M; Olerup O; Ringden O; Winiarski J
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3535
No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ljungman P; Winiarski J; Ericzon B; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3530
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation
Sparrelid E; Hagglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringden O
Other: BONE MARROW TRANSPLANTATION. 1995;15(5):799-801
BONE-MARROW TRANSPLANTATION IN 2 CHILDREN WITH CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA
HENTER JJ; WINIARSKI J; LJUNGMAN P; RINGDEN O; OST A
Visa fler

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2027
Professor, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2020-2024
Professor, Senior, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2017-2020
Adjungerad Professor, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2011-2017
Adjungerad Professor, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2003-2009

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI